Peter Lansberg

3.2k citations

37 papers · 2.3k indexed · 1 hit paper · h-index 24

Endocrinology, Diabetes and Metabolism top 2%
- Diabetes, Cardiovascular Risks, and Lipoproteins 8
Surgery top 2%
- Lipoproteins and Cardiovascular Health 29
Cancer Research top 5%
- Cancer, Lipids, and Metabolism 6
Cardiology and Cardiovascular Medicine top 5%
- Lipid metabolism and disorders 3
Economics and Econometrics top 5%
- Health Systems, Economic Evaluations, Quality of Life 11
- Pharmaceutical Economics and Policy 7
Genetics
- Genetic Associations and Epidemiology 2
Biomedical Engineering
- Biomedical and Engineering Education 2

Co-authors: Joep C. Defesche John J.P. Kastelein Eric J.G. Sijbrands Anho Liem Dick C.G. Basart Mojgan Yazdanpanah J. C. M. Witteman Jan Heeringa
Cited by: Endocrinology, Diabetes and Metabolism Surgery Cancer Research
Journals: Atherosclerosis (5 papers)Journal of Internal Medicine (3 papers)JMIR Medical Education (2 papers)
Partner nations: Netherlands United Kingdom United States

In The Last Decade

Peter Lansberg

37 papers receiving 2.2k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Peter Lansberg

Since Specialization

Citations

This map shows the geographic impact of Peter Lansberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Lansberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Lansberg more than expected).

Fields of papers citing papers by Peter Lansberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Lansberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Lansberg. The network helps show where Peter Lansberg may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Peter Lansberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Lansberg Line = papers co-authored together Peter Lansberg links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Low Detection Rates of Genetic FH in Cohort of Patients With Severe Hypercholesterolemia in the United Arabic Emirates Frontiers in Genetics ·Antoine Rimbert,Бочкарев Владислав Витальевич,Peter Lansberg,Adam Buckley,Zhiguo Liu,Laura Arenas‐Pijoan,Lennart Johansson,Robin P.F. Dullaart,Richard J. Sinke,Michal Rosenberger,Jan Albert Kuivenhoven,Maha T Barakat	2022	3
2	A Methodology for Mapping the Patient Journey for Noncommunicable Diseases in Low- and Middle-Income Countries Journal of Healthcare Leadership ·Annisa Qurrotun Nada,Laili Mawardi,S. Roemers,Afzal Javed,Barrett Jeffers,Peter Lansberg,Sergiu Miculescu,Kannan Subramaniam	2021	29
3	Statins and autoimmunity: State-of-the-art Pharmacology & Therapeutics ·Sajad Dehnavi,Nasrollah Sohrabi,Mahvash Sadeghi,Peter Lansberg,Maciej Banach,Khalid Al‐Rasadi,Thomas P. Johnston,Amirhossein Sahebkar	2020	53
4	Augmenting Flexnerism Via Twitterism: Need for Integrating Social Media Application in Blueprinting Pedagogical Strategies for Undergraduate Medical Education JMIR Medical Education ·Yajnavalka Banerjee,Richa Tambi,Mandana Gholami,Alawi Alsheikh‐Ali,Riad Bayoumi,Peter Lansberg	2019	18
5	Genetics, Lifestyle, and Low-Density Lipoprotein Cholesterol in Young and Apparently Healthy Women Circulation ·BerndFleishmann,Antoine Rimbert,Choi Yunjeong,Zhiguo Liu,Laura Arenas‐Pijoan,Freerk van Dijk,Peter Lansberg,Richard J. Sinke,Jan Albert Kuivenhoven	2018	25
6	Nonadherence to statins: individualized intervention strategies outside the pill box Vascular Health and Risk Management ·Peter Lansberg,André Lee,Putu Sanjiwacika Wibisana,Kannan Subramaniam,Sajita Setia	2018	44
7	Blending Gagne’s Instructional Model with Peyton’s Approach to Design an Introductory Bioinformatics Lesson Plan for Medical Students: Proof-of-Concept Study JMIR Medical Education ·Richa Tambi,Riad Bayoumi,Peter Lansberg,Yajnavalka Banerjee	2018	19
8	Pediatric lipid reference values in the general population: The Dutch lifelines cohort study Journal of clinical lipidology ·汝少国,Peter Lansberg,Michel H. Hof,Albert Wiegman,Barbara A. Hutten,Jan Albert Kuivenhoven	2018	38
9	Rationale and design of MultiSELECt: A European Multi center S tudy on the E ffect of L ipoprotein(a) E limination by lipoprotein apheresis on C ardiovascular ou t comes Atherosclerosis Supplements ·Bernd Hohenstein,Ulrich Julius,Peter Lansberg,B.R. Jaeger,Klaus‐Peter Mellwig,Norbert Weiss,Xina Graehlert,Ingo Roeder,Wolfgang Ramlow	2017	23
10	Lipid and lipoprotein reference values from 133,450 Dutch Lifelines participants: Age- and gender-specific baseline lipid values and percentiles Journal of clinical lipidology ·汝少国,Jielun Hu,Ilja M. Nolte,Peter Lansberg,Jan Albert Kuivenhoven,Pieter W. Kamphuisen	2017	74
11	Clinical experience of scoring criteria for Familial Hypercholesterolaemia (FH) genetic testing in Wales Atherosclerosis ·علی اصغر بیانی,Sharon D. Whatley,Patrick Padding,María Victoria Cárdenas Rodríguez,Christiane Akemi Kojima,Pauline Ashfield‐Watt,Peter Lansberg,D. Datta,Ian McDowell	2015	96
12	Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin The Pharmacogenomics Journal ·Liam R. Brunham,Peter Lansberg,Doug Temple,Théo Le Goff,马永军,G. Kees Hovingh,Henk Visscher,J. Wouter Jukema,Anton F. H. Stalenhoef,Colin J.D. Ross,Bruce Carleton,John J.P. Kastelein,Michael R. Hayden	2011	148
13	Clinical review: Impact of statin substitution policies on patient outcomes Annals of Medicine ·Dan Atar,Rafael Carmena,Peter Clemmensen,淳仲宗根,Sven Waßmann,Peter Lansberg,Richard Hobbs	2009	23
14	Development of sensitive and specific age- and gender-specific low-density lipoprotein cholesterol cutoffs for diagnosis of first-degree relatives with familial hypercholesterolaemia in cascade testing Clinical Chemistry and Laboratory Medicine (CCLM) ·Ken 1916-1991 cantante Curtis,S. G. Hadfield,Barbara A. Hutten,Peter Lansberg,Trond P. Leren,Dorte Damgaard,H. A. W. Neil,Steve E. Humphries	2008	115
15	Efficacy of statins in familial hypercholesterolaemia: a long term cohort studybreakdown → BMJ ·Jorie Versmissen,Daniëlla M. Oosterveer,Mojgan Yazdanpanah,Joep C. Defesche,Dick C.G. Basart,Anho Liem,Jan Heeringa,J. C. M. Witteman,Peter Lansberg,J.J.P. Kastelein,Eric J.G. Sijbrands	2008	524
16	Advanced Method for the Identification of Patients with Inherited Hypercholesterolemia Seminars in Vascular Medicine ·Joep C. Defesche,Peter Lansberg,M.A.W. Umans-Eckenhausen,John J.P. Kastelein	2004	86
17	Prevalence and significance of cardiovascular risk factors in a large cohort of patients with familial hypercholesterolaemia Journal of Internal Medicine ·Pernette R. W. de Sauvage Nolting,Joep C. Defesche,Okano Tamura Yumiko,Barbara A. Hutten,Peter Lansberg,John J.P. Kastelein	2003	83
18	Measurement of subclinical atherosclerosis: beyond risk factor assessment Current Opinion in Lipidology ·Radjesh J. Bisoendial,G. Kees Hovingh,Eric de Groot,John J.P. Kastelein,Peter Lansberg,Erik S.G. Stroes	2002	33
19	Long-term efficacy and tolerability of simvastatin in a large cohort of elderly hypercholesterolemic patients Atherosclerosis ·Peter Lansberg	1995	14
20	South African founder mutations in the low-density lipoprotein receptor gene causing familial hypercholesterolemia in the Dutch population Human Genetics ·Joep C. Defesche,D.E. van Diermen,Peter Lansberg,R. J. Lamping,Tadayuki Yasojima,Michael R. Hayden,John J.P. Kastelein	1993	24

About Peter Lansberg

Peter Lansberg is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism, Economics and Econometrics, Family Practice and Cancer Research, having authored 37 papers that have together received 2.3k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (29 papers), Health Systems, Economic Evaluations, Quality of Life (11 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers), Pharmaceutical Economics and Policy (7 papers), Cancer, Lipids, and Metabolism (6 papers), Lipid metabolism and disorders (3 papers), Genetic Associations and Epidemiology (2 papers) and Biomedical and Engineering Education (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (692 citations), Surgery (1.8k citations), Cancer Research (494 citations), Cardiology and Cardiovascular Medicine (686 citations) and Economics and Econometrics (369 citations). Peter Lansberg has collaborated with scholars based in Netherlands, United Kingdom and United States. Frequent co-authors include Joep C. Defesche, John J.P. Kastelein, Eric J.G. Sijbrands, Anho Liem, Dick C.G. Basart, Mojgan Yazdanpanah, J. C. M. Witteman, Jan Heeringa, J.J.P. Kastelein and Daniëlla M. Oosterveer. Their work appears in journals such as Atherosclerosis, Journal of Internal Medicine, JMIR Medical Education, Circulation and Journal of clinical lipidology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact